Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
Clinical trial NCT04074421 · UNKNOWN
Trial details
- NCT number
- NCT04074421
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-10
- Primary completion
- 2022-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.